CDZ173/Leniolisib, CDZ173/Leniolisib
LE 3301
Phase 3 small_molecule active
Quick answer
CDZ173/Leniolisib, CDZ173/Leniolisib for Activated Phosphoinositide 3-Kinase Delta Syndrome is a Phase 3 program (small_molecule) at Pharming Technologies B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharming Technologies B.V.
- Indication
- Activated Phosphoinositide 3-Kinase Delta Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active